Nanexa AB (publ) (STO:NANEXA)
Sweden
· Delayed Price · Currency is SEK 3.350
-0.410 (-10.90%)
Apr 29, 2026, 5:29 PM CET
Nanexa AB Revenue
In the year 2025, Nanexa AB had annual revenue of 55.94M SEK with 19.80% growth. Nanexa AB had revenue of 34.82M in the quarter ending December 31, 2025, with 222.34% growth.
Revenue
55.94M
Revenue Growth
+19.80%
P/S Ratio
11.06
Revenue / Employee
3.73M
Employees
15
Market Cap
618.84M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 55.94M | 9.24M | 19.80% |
| Dec 31, 2024 | 46.69M | -12.47M | -21.07% |
| Dec 31, 2023 | 59.16M | 31.99M | 117.72% |
| Dec 31, 2022 | 27.17M | 9.16M | 50.87% |
| Dec 31, 2021 | 18.01M | -2.85M | -13.66% |
| Dec 31, 2020 | Pro | Pro | Pro |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Moberg Pharma AB | 13.54M |
| Cinclus Pharma Holding AB | 57.47M |
| Enzymatica AB | 53.90M |
| Orexo AB | 26.00M |
| Dicot Pharma AB | 200.00K |
| EQL Pharma AB | 425.75M |
| Klaria Pharma Holding AB (publ.) | 8.99M |
| Cereno Scientific AB | 44.27M |
Nanexa AB News
- 2 years ago - Nanexa AB Earnings Call Transcript: Q1 2024 - Transcripts
- 5 years ago - Nanexa AB Transcript: Business Update - Transcripts